| Rhodium-catalyzed asymmetric ring opening of oxabicyclic alkenes with organoboronic acids M Lautens, C Dockendorff, K Fagnou, A Malicki Organic Letters 4 (8), 1311-1314, 2002 | 254 | 2002 |
| Applications of multicomponent reactions for the synthesis of diverse heterocyclic scaffolds JD Sunderhaus, C Dockendorff, SF Martin Organic letters 9 (21), 4223-4226, 2007 | 219 | 2007 |
| Synthesis of dihydronaphthalenes via aryne Diels− Alder reactions: scope and diastereoselectivity C Dockendorff, S Sahli, M Olsen, L Milhau, M Lautens Journal of the American Chemical Society 127 (43), 15028-15029, 2005 | 166 | 2005 |
| Cytoprotective activated protein C averts Nlrp3 inflammasome–induced ischemia-reperfusion injury via mTORC1 inhibition S Nazir, I Gadi, MM Al-Dabet, A Elwakiel, S Kohli, S Ghosh, J Manoharan, ... Blood, The Journal of the American Society of Hematology 130 (24), 2664-2677, 2017 | 153 | 2017 |
| Palladium (II) catalyst systems for the addition of boronic acids to bicyclic alkenes: New scope and reactivity M Lautens, C Dockendorff Organic Letters 5 (20), 3695-3698, 2003 | 134 | 2003 |
| Discovery of μ-opioid selective ligands derived from 1-aminotetralin scaffolds made via metal-catalyzed ring-opening reactions C Dockendorff, S Jin, M Olsen, M Lautens, M Coupal, L Hodzic, N Spear, ... Bioorganic & medicinal chemistry letters 19 (4), 1228-1232, 2009 | 109 | 2009 |
| Rhodium-catalyzed asymmetric allylic substitution with boronic acid nucleophiles F Menard, TM Chapman, C Dockendorff, M Lautens Organic Letters 8 (20), 4569-4572, 2006 | 98 | 2006 |
| Synthesis of diverse heterocyclic scaffolds via tandem additions to imine derivatives and ring-forming reactions JD Sunderhaus, C Dockendorff, SF Martin Tetrahedron 65 (33), 6454-6469, 2009 | 97 | 2009 |
| Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar O Aisiku, CG Peters, K De Ceunynck, CC Ghosh, JR Dilks, ... Blood, The Journal of the American Society of Hematology 125 (12), 1976-1985, 2015 | 95 | 2015 |
| PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury K De Ceunynck, CG Peters, A Jain, SJ Higgins, O Aisiku, JL Fitch-Tewfik, ... Proceedings of the National Academy of Sciences 115 (5), E982-E991, 2018 | 72 | 2018 |
| Concise Enantioselective Total Syntheses of (+)‐Homochelidonine, (+)‐Chelamidine, (+)‐Chelidonine, (+)‐Chelamine and (+)‐Norchelidonine by a PdII‐Catalyzed … MJ Fleming, HA McManus, A Rudolph, WH Chan, J Ruiz, C Dockendorff, ... Chemistry–A European Journal 14 (7), 2112-2124, 2008 | 72 | 2008 |
| Discovery of 1, 3-diaminobenzenes as selective inhibitors of platelet activation at the PAR1 receptor C Dockendorff, O Aisiku, L VerPlank, JR Dilks, DA Smith, SF Gunnink, ... ACS Medicinal Chemistry Letters 3 (3), 232-237, 2012 | 59 | 2012 |
| Rhodium-catalyzed allylation reactions MB Thoke, Q Kang Synthesis 51 (13), 2585-2631, 2019 | 54 | 2019 |
| Macrocyclic Hedgehog pathway inhibitors: optimization of cellular activity and mode of action studies C Dockendorff, MM Nagiec, M Weïwer, S Buhrlage, A Ting, PP Nag, ... ACS Medicinal Chemistry Letters 3 (10), 808-813, 2012 | 49 | 2012 |
| Monitoring Replication Protein A (RPA) dynamics in homologous recombination through site-specific incorporation of non-canonical amino acids N Pokhrel, S Origanti, EP Davenport, D Gandhi, K Kaniecki, RA Mehl, ... Nucleic acids research 45 (16), 9413-9426, 2017 | 47 | 2017 |
| Synthesis of Protected l-4-[Sulfono(difluoromethyl)]phenylalanine and Its Incorporation into a Peptide S Liu, C Dockendorff, SD Taylor Organic Letters 3 (10), 1571-1574, 2001 | 40 | 2001 |
| Identification of ML359 as a small molecule inhibitor of protein disulfide isomerase C Khodier, L VerPlank, PP Nag, J Pu, J Wurst, T Pilyugina, C Dockendorff, ... Probe Reports from the NIH Molecular Libraries Program [Internet], 2014 | 34 | 2014 |
| Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles W Youngsaye, C Dockendorff, B Vincent, CL Hartland, JA Bittker, ... Bioorganic & medicinal chemistry letters 22 (9), 3362-3365, 2012 | 24 | 2012 |
| Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression MM Al-Dabet, K Shahzad, A Elwakiel, A Sulaj, S Kopf, F Bock, I Gadi, ... Nature Communications 13 (1), 5062, 2022 | 23 | 2022 |
| Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells DM Gandhi, MW Majewski, R Rosas Jr, K Kentala, TJ Foster, E Greve, ... Bioorganic & medicinal chemistry 26 (9), 2514-2529, 2018 | 23 | 2018 |
